BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1394812)

  • 1. A prospective randomized study of prophylaxis of tumor recurrence following transurethral resection of superficial bladder cancer--intravesical thio-TEPA versus oral UFT.
    Hirao Y; Okajima E; Ozono S; Samma S; Sasaki K; Hiramatsu T; Babaya K; Watanabe S; Maruyama Y
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S26-30. PubMed ID: 1394812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prophylactic effect of UFT in combination with intravesical chemotherapy on the recurrence of superficial bladder tumor].
    Yoshida O; Kakehi Y; Nishio Y; Tomoyoshi T; Konami T; Usui T; Igawa M; Takenaka I; Fujita K
    Hinyokika Kiyo; 1992 Dec; 38(12):1437-43. PubMed ID: 1288238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic chemotherapy for primary and recurrent superficial bladder cancer: preliminary results. The Hokkaido University Bladder Cancer Collaborating Group.
    Togashi M; Shinohara N; Toyota K; Koyanagi T; Maru A; Fujieda J; Kawakura K; Nishida T; Ohashi N
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S21-5. PubMed ID: 1394811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylactic combination therapy after TUR of superficial bladder cancer].
    Ao T; Uchida T; Yokoyama E; Kawakami T; Adachi K; Mashimo S; Endo T; Koshiba K
    Hinyokika Kiyo; 1993 Nov; 39(11):987-91. PubMed ID: 7505523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparative clinical trial of UFT medication and intravesical BCG in the recurrence of superficial bladder cancer. Study Group of UFT and BCG adjuvant therapy for bladder cancer].
    Oda H; Seki N; Nabeshima S; Oda T; Nishio S; Yokoyama M; Iwata H; Takeuchi M; Matsumoto A; Terado T
    Gan To Kagaku Ryoho; 1990 Oct; 17(10):2051-5. PubMed ID: 2221929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic oral UFT therapy for superficial bladder cancer.
    Kubota Y; Hosaka M; Fukushima S; Kondo I
    Cancer; 1993 Mar; 71(5):1842-5. PubMed ID: 8448746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic treatment for superficial bladder cancer following transurethral resection.
    Hirao Y; Okajima E; Ohara S; Ozono S; Hiramatsu T; Yoshida K; Yamada K; Aoyama H; Hashimoto M; Watanabe S
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S85-90. PubMed ID: 3117402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy with early intravesical instillation of adriamycin and long-term oral administration of 5-fluorouracil in superficial bladder cancer. The Kyushu University Urological Oncology Group.
    Ueda T; Naito S; Iguchi A; Sagiyama K; Osada Y; Ariyoshi A; Omoto T; Kumazawa J
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S31-6. PubMed ID: 1394813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative clinical trial of UFT treatment and intravesical adriamycin instillation to prevent recurrence of superficial bladder cancer].
    Masuda F; Mori Y; Torii S; Kawashima Y; Kobari T; Hosobe T
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):505-8. PubMed ID: 1558400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 2-b interferon and farmarubicin in the prophylaxis of recurrence of superficial transitional cell carcinoma of the urinary bladder.
    Cervenakov I; Szoldova K; Mardiak J; Chovan D; Mala M; Slavov D
    Bratisl Lek Listy; 2000; 101(6):317-20. PubMed ID: 11039202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Short-term intravesical instillation of pirarubicin (THP) in prophylactic treatment after transurethral resection of superficial bladder tumor].
    Kuroda K; Ishii N; Fukasawa K; Shirai M; Tajima M; Matsushima M; Miura K; Takanami M; Matsuhashi M; Kuwabara T; Matsumoto H; Sugita M
    Hinyokika Kiyo; 1998 Aug; 44(8):547-52. PubMed ID: 9783189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylactic effect of UFT on the recurrence of bladder cancer].
    Naito K; Hisazumi H; Saka A; Nakamura T; Kanda S; Mikawa I; Ejiri S; Miyagi T; Katsumi T; Kitagawa K
    Hinyokika Kiyo; 1990 Apr; 36(4):487-94. PubMed ID: 2116083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The best management of superficial bladder tumours: comparing TUR alone versus TUR combined with intravesical chemotherapy modalities?
    Altay B; Girgin C; Kefi A; Cikili N
    Int Urol Nephrol; 2000; 32(1):53-8. PubMed ID: 11057773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of prophylactic intravesical chemotherapy with epirubicin in the treatment of superficial bladder cancer. Tokyo Women's Medical College Bladder Cancer Collaborating Group.
    Ryoji O; Toma H; Nakazawa H; Goya N; Okumura T; Sonoda T; Kihara T; Tanabe K; Onizuka S; Tomoe H
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S60-4. PubMed ID: 7994789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT; Yildirim U; Zorlu F; Ozen H
    J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach.
    Schulze M; Stotz N; Rassweiler J
    J Endourol; 2007 Dec; 21(12):1533-41. PubMed ID: 18186695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic intravesical instillation chemotherapy against recurrence after a transurethral resection of superficial bladder cancer: a randomized controlled trial of doxorubicin plus verapamil versus doxorubicin alone. The Kyushu University Urological Oncology Group.
    Naito S; Kotoh S; Omoto T; Osada Y; Sagiyama K; Iguchi A; Ariyoshi A; Hiratsuka Y; Kumazawa J
    Cancer Chemother Pharmacol; 1998; 42(5):367-72. PubMed ID: 9771950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of intravesical instillation of Thio-Tepa on the recurrence rate of bladder tumors.
    Asahi T; Matsumura Y; Tanahashi T; Yoshimoto J; Kaneshige T; Fujita Y; Ohmori H
    Acta Med Okayama; 1980 Feb; 34(1):43-9. PubMed ID: 6446839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic effect of triethylenethiophosphoramide on the recurrence rate of superficial bladder tumors.
    Mukamel E; Zitron S; Nissenkorn I; Servadio C
    Isr J Med Sci; 1980; 16(9-10):714-6. PubMed ID: 6776072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.